Page 17 - Nifty50

RBI's liquidity shot lifts pharma, bank stocks; Sensex leaps 424 pts

The RBI's well guarded measures which, analysts believe, are tuned to the evolving situation may support the economy going forward

Sensex falls 64 pts; smallcaps outperform; SBI Life jumps 5%, RIL drops 2%

SBI Life (up over 5 per cent) settled the day as the top Nifty gainer, trailed by Bharti Airtel, Adani Ports, Tata Steel, HUL, Asian Paints, and Maruti Suzuki

Nifty50 has found support at its 100-day moving average twice

On Friday, the index closed at 14,631, after dropping 264 points, or 1.8 per cent. Despite the sharp fall, the 50-share index currently trades above its 100-DMA of 14,459

Sensex tanks 984 pts, ends at 48,782; financials crack; Nifty Pharma up 1%

On a weekly basis, both the frontline indices snapped their 3-week losing streak and added around 2 per cent higher each

India's benchmark stock indices slide 2% as Covid-19 risks heighten

Bank stocks lead the fall; FIIs pull out Rs 3,465 crore

F&O expiry: Sensex up 32 pts, ends April series below 50,000; metals shine

Among key sectoral indices, robust global demand lifted the Nifty Metal index to record peak of 4,869 on the NSE today

Investors look beyond Covid cases' surge; Sensex zooms 790 pts; banks rally

CLSA opines that the surge in Covid cases in Maharashtra may taper in May as the state is in its fourth-month of the second wave. This, it believes, will be positive for the markets

RIL, pvt banks take Sensex 558 pts up; Nifty tops 14,650; Nifty Metal up 3%

Hindalco, L&T, Tata Steel, Divis Labs, Reliance Industries, Bajaj Finance, and SBI were the top gainers on the 50-share pack

Financials lift Sensex 508 pts up; pharma stocks, HCL Tech miss D-St rally

Investors booked profit in the pharma counters after a healthy rally over the past week. The index settled 0.87 per cent down.

Indices decline for 3rd straight week; Sensex slips 202 pts, ends below 48K

The overall market breadth remained in the favour of the bulls, courtesy rally in the broader markets

Investors dump FMCG for financials; Sensex gains 375 pts, ends above 48K

From a low of 30,555 hit earlier in the day, the Nifty Bank index ended at 31,783, up 2.15 per cent

Localised lockdowns weigh; Sensex declines 244 points amid volatility

The broader markets, however, managed to duck the bear onslaught and supported the overall market breadth

'Disconnect between markets and the reality of on-ground Covid situation'

Given the weak domestic cues, leading experts see more volatility over the next few sessions

Investors lose Rs 3.6 trillion as Sensex falls 883 pts on Covid-19 woes

The Nifty Pharma index was the only index that ended in thee green, up 0.17 per cent

Indices end choppy day in the green; Sensex up 28 pts; Wipro soars 9%

Wipro, which jumped 10 per cent in the intra-day trade and hit a record high of Rs 474 on the NSE, ended as the top gainer on the Nifty after clocking its best performance in Q4 in a decade

Fag-end buying lifts Sensex 260 pts, Nifty tops 14,550; Infosys dips 2.5%

Overall, the Nifty Bank, Pharma, Metal, IT, Financial Services, and Private Bank indices ended up to 1.4 per cent higher

Financial, RIL drive Sensex 661 pts up; Nifty tops 14,500; TCS falls 4%

The Nifty Bank, Private Bank, Financial Services, Metal, and Realty indices gained between 3 per cent and 4 per cent.

What could India Inc's Q4 report card look like? Here's a glimpse

As per some experts, Nifty50 could possibly post the highest earnings growth in a decade in a financial year that was marked by turbulent times in the form of pandemic to lockdowns to GDP contractions

Sensex dips 155 pts as record Covid cases weigh on indices; pharma stks up

Trends in the broader markets were mixed as the S&P BSE SmallCap index closed 0.7 per cent higher while the S&P BSE MidCap index dipped 0.07 per cent.

Nomura sees Nifty at 15,340 by March'22; sees risks to FII flows in FY22

Markets, Nomura believes, are dealing with three headwinds - the resurgence of Covid-19 cases; inflationary pressure with the rise in commodity prices; and rich valuations